Reducing vasomotor symptoms with acupuncture in breast cancer patients treated with adjuvant tamoxifen: a randomized controlled trial

被引:0
|
作者
Annelie Liljegren
Pia Gunnarsson
Britt-Marie Landgren
Ninna Robéus
Hemming Johansson
Samuel Rotstein
机构
[1] Radiumhemmet,Department of Oncology
[2] Karolinska University Hospital and Karolinska Institutet,Department of Physiotherapy
[3] Karolinska University Hospital,Department of Gynecology
[4] Karolinska University Hospital and Karolinska Institutet,Department of Oncology
[5] Gynekologmottagningen Mörby Centrum Danderyd,Department of Oncology
[6] Karolinska University Hospital,undefined
[7] Karolinska University Hospital and Karolinska Institutet,undefined
来源
关键词
Acupuncture; Sham; Hot flush; Breast cancer; Adjuvant; Tamoxifen;
D O I
暂无
中图分类号
学科分类号
摘要
To evaluate true acupuncture to control acupuncture (CTRL) (non-insertive stimulation at non-acupuncture points) in breast cancer patients treated with adjuvant tamoxifen suffering from hot flushes and sweatings. Eighty-four patients were randomized to receive either true acupuncture or CTRL twice a week for 5 weeks. Seventy-four patients were treated according to the protocol. In the true acupuncture group 42% (16/38) reported improvements in hot flushes after 6 weeks compared to 47% (17/36) in the CTRL group (95% CI, −28 to 18%). Both groups reported improvement regarding severity and frequencies in hot flushes and sweatings but no statistical difference was found between the groups. In a subanalysis regarding the severity of sweatings at night a statistically significant difference P = 0.03 was found in the true acupuncture group. Former experience of true acupuncture did not influence the perception of true acupuncture or CTRL. No significant differences in hormonal levels were found before and after treatment. In conclusion, convincing data that true acupuncture is more effective than CTRL in reducing vasomotor symptoms is still lacking. Our study shows that both true and CTRL reduce vasomotor symptoms in breast cancer patients treated with adjuvant tamoxifen.
引用
收藏
页码:791 / 798
页数:7
相关论文
共 50 条
  • [41] Delayed adjuvant tamoxifen:: Ten-year results of a collaborative randomized controlled trial in early breast cancer (TAM-02 trial)
    Delozier, T
    Switsers, O
    Génot, JY
    Ollivier, JM
    Héry, M
    Namer, M
    Fresney, M
    Kerbrat, P
    Veyret, C
    de Lafontan, B
    Janvier, M
    Macé-Lesech, J
    ANNALS OF ONCOLOGY, 2000, 11 (05) : 515 - 519
  • [42] CARDIAC AND VASCULAR MORBIDITY IN WOMEN RECEIVING ADJUVANT TAMOXIFEN FOR BREAST-CANCER IN A RANDOMIZED TRIAL
    MCDONALD, CC
    ALEXANDER, FE
    WHYTE, BW
    FORREST, AP
    STEWART, HJ
    BRITISH MEDICAL JOURNAL, 1995, 311 (7011): : 977 - 980
  • [43] Late delayed adjuvant tamoxifen in early breast cancer. Results of a cooperative randomized trial
    Delozier, T
    Switsers, O
    Genot, JY
    Ollivier, JM
    Hery, M
    Namer, M
    Frenay, M
    Kerbrat, P
    Julien, JP
    Naja, A
    Janvier, M
    MaceLesech, J
    BULLETIN DU CANCER, 1997, 84 (01) : 25 - 30
  • [44] Prophylactic Use of Levonorgestrel-Releasing Intrauterine System in Women With Breast Cancer Treated With Tamoxifen A Randomized Controlled Trial
    Wong, Alice W. Y.
    Chan, Symphorosa S. C.
    Yeo, Winnie
    Yu, Mei-Yung
    Tam, Wing-Hung
    OBSTETRICS AND GYNECOLOGY, 2013, 121 (05): : 943 - 950
  • [45] Paced Respiration for Vasomotor and Other Menopausal Symptoms: A Randomized, Controlled Trial
    Carpenter, Janet S.
    Burns, Debra S.
    Wu, Jingwei
    Otte, Julie L.
    Schneider, Bryan
    Ryker, Kristin
    Tallman, Eileen
    Yu, Menggang
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (02) : 193 - 200
  • [46] Paced Respiration for Vasomotor and Other Menopausal Symptoms: A Randomized, Controlled Trial
    Janet S. Carpenter
    Debra S. Burns
    Jingwei Wu
    Julie L. Otte
    Bryan Schneider
    Kristin Ryker
    Eileen Tallman
    Menggang Yu
    Journal of General Internal Medicine, 2013, 28 : 193 - 200
  • [47] Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy
    Naoko Honma
    Rie Horii
    Takuji Iwase
    Shigehira Saji
    Mamoun Younes
    Yoshinori Ito
    Futoshi Akiyama
    Breast Cancer, 2013, 20 : 323 - 330
  • [48] A CONTROLLED TRIAL OF ADJUVANT TAMOXIFEN, WITH OR WITHOUT PREDNISOLONE, IN POSTMENOPAUSAL WOMEN WITH OPERABLE BREAST-CANCER
    FENTIMAN, IS
    HOWELL, A
    HAMED, H
    LEE, SM
    RANSON, M
    WALL, J
    CHAUDARY, MA
    ASH, CM
    GREGORY, WM
    SELLWOOD, RA
    RUBENS, RD
    BRITISH JOURNAL OF CANCER, 1994, 70 (04) : 729 - 731
  • [49] Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy
    Honma, Naoko
    Horii, Rie
    Iwase, Takuji
    Saji, Shigehira
    Younes, Mamoun
    Ito, Yoshinori
    Akiyama, Futoshi
    BREAST CANCER, 2013, 20 (04) : 323 - 330
  • [50] Mepitel® film versus standard care for the prevention of skin toxicity in breast cancer patients treated with adjuvant radiotherapy: A randomized controlled trial
    Valcarenghi, Dario
    Tolotti, Angela
    Vees, Hansjoerg
    Torri, Valter
    Liptrott, Sarah Jayne
    Presta, Giovanni
    Puliatti, Andrea
    Moser, Laura
    Sari, Davide
    Valli, Mariacarla
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2025, 52